D 3263
Alternative Names: D-3263; D-3263 HCl; EC D-3263 HCl; Enteric coated D-3263 HCl; TRPM8Latest Information Update: 24 Oct 2021
At a glance
- Originator Dendreon Corporation
- Class Antineoplastics; Small molecules
- Mechanism of Action Apoptosis stimulants; TRPM8 protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Benign prostatic hyperplasia; Solid tumours
Most Recent Events
- 31 Dec 2013 Suspended - Phase-I for Solid tumours in USA (PO)
- 31 Dec 2013 Suspended - Preclinical for Benign prostatic hyperplasia in USA (PO)
- 01 Dec 2011 Dendreon completes its phase I trial for Solid tumours in USA (NCT00839631)